Sources

6 Total Sources

Eli Lilly Buys AtaiBeckley for Up to $3.8 Billion as Psychedelic Drug Bets Accelerate

Left40%
Center60%
CNBC2d ago
Eli Lilly to Acquire AtaiBeckley for $3.8 Billion, Boosting Psychedelic Drug Market
linkedin2d ago
𝐖𝐞𝐞𝐤 𝐢𝐧 𝐑𝐞𝐯𝐢𝐞𝐰: Lilly lended validation to psychedelics with its $2.8 B+ acquisition of AtaiBeckley and recent IPO Hemab traded up on a readout of its Glanzmann Thrombasthenia… | BiotechTV
Reuters2d ago
Lilly enters psychedelic drug race with up to $3.8 billion AtaiBeckley deal | Reuters
MSN2d ago
Lilly to buy AtaiBeckley in $3.8B psychedelic push
CP242d ago
Eli Lilly enters psychedelic drug race with AtaiBeckley deal
Financial Times2d ago
Eli Lilly buys psychedelic biotech backed by Peter Thiel